NO20001585L - Orale sammensetninger av levosimendan - Google Patents

Orale sammensetninger av levosimendan

Info

Publication number
NO20001585L
NO20001585L NO20001585A NO20001585A NO20001585L NO 20001585 L NO20001585 L NO 20001585L NO 20001585 A NO20001585 A NO 20001585A NO 20001585 A NO20001585 A NO 20001585A NO 20001585 L NO20001585 L NO 20001585L
Authority
NO
Norway
Prior art keywords
levosimendan
oral compositions
oral
compositions
Prior art date
Application number
NO20001585A
Other languages
English (en)
Other versions
NO20001585D0 (no
NO320047B1 (no
Inventor
Maarit Bockman
Ilka Larma
Saila Antila
Lasse Lehtonen
Maarit Harjula
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20001585L publication Critical patent/NO20001585L/no
Publication of NO20001585D0 publication Critical patent/NO20001585D0/no
Publication of NO320047B1 publication Critical patent/NO320047B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20001585A 1997-09-26 2000-03-27 Sammensetning for oral administrering NO320047B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI973804A FI973804A7 (fi) 1997-09-26 1997-09-26 Levosimendaanin oraalisia koostumuksia
PCT/FI1998/000753 WO1999016443A1 (en) 1997-09-26 1998-09-24 Oral compositions of levosimendan

Publications (3)

Publication Number Publication Date
NO20001585L true NO20001585L (no) 2000-03-27
NO20001585D0 NO20001585D0 (no) 2000-03-27
NO320047B1 NO320047B1 (no) 2005-10-17

Family

ID=8549609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001585A NO320047B1 (no) 1997-09-26 2000-03-27 Sammensetning for oral administrering

Country Status (35)

Country Link
US (1) US6355269B1 (no)
EP (1) EP1014987B1 (no)
JP (1) JP4493840B2 (no)
KR (1) KR100762022B1 (no)
CN (1) CN1149994C (no)
AR (1) AR013519A1 (no)
AT (1) ATE260659T1 (no)
AU (1) AU732489B2 (no)
BG (1) BG64746B1 (no)
BR (1) BR9813213A (no)
CA (1) CA2304702C (no)
CZ (1) CZ294984B6 (no)
DE (1) DE69822172T2 (no)
DK (1) DK1014987T3 (no)
EA (1) EA001647B1 (no)
EE (1) EE03854B1 (no)
ES (1) ES2217580T3 (no)
FI (1) FI973804A7 (no)
GE (1) GEP20032943B (no)
HR (1) HRP20000171B1 (no)
HU (1) HUP0003757A3 (no)
ID (1) ID24486A (no)
IL (1) IL134802A (no)
MX (1) MXPA00002956A (no)
MY (1) MY118156A (no)
NO (1) NO320047B1 (no)
NZ (1) NZ503207A (no)
PL (1) PL190862B1 (no)
PT (1) PT1014987E (no)
RS (1) RS49708B (no)
SI (1) SI1014987T1 (no)
SK (1) SK283187B6 (no)
TR (1) TR200000635T2 (no)
WO (1) WO1999016443A1 (no)
YU (1) YU17700A (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606474D0 (en) * 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
FI980902A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia
FI980901A7 (fi) 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI20000577A0 (fi) * 2000-03-13 2000-03-13 Orion Yhtymae Oy Pyridatsinyylifenyylihydratsoneja
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
EP1642571A3 (en) * 2000-12-22 2007-06-27 Baxter International Inc. Method for preparing submicron particle suspensions
US6869617B2 (en) 2000-12-22 2005-03-22 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
JP2005504090A (ja) 2001-09-26 2005-02-10 バクスター・インターナショナル・インコーポレイテッド 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
EP2454241B1 (en) * 2009-07-14 2014-04-02 Cipla Limited Process for preparing levosimendan and intermediates for use in the process
CN104418810A (zh) * 2013-09-04 2015-03-18 北京博时安泰科技发展有限公司 一种左西孟旦的合成新路线
CN103554032A (zh) * 2013-11-12 2014-02-05 江苏正大清江制药有限公司 高光学纯度(-)-6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2h)-哒嗪酮的制备方法
ITMI20132185A1 (it) * 2013-12-23 2015-06-24 Edmond Pharma Srl Polimorfi di levosimendan
CN104987310A (zh) * 2015-06-03 2015-10-21 青岛农业大学 左西孟旦的合成工艺
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
WO2021126884A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HF-pEF)
CN111548310B (zh) * 2020-05-12 2021-07-02 成都欣捷高新技术开发股份有限公司 一种左西孟旦钠晶型及其制备方法
CN111718299B (zh) * 2020-07-23 2023-03-10 成都欣捷高新技术开发股份有限公司 一种左西孟旦钠晶型b及其制备方法
US11760730B2 (en) * 2021-01-11 2023-09-19 Navinta, Llc Process for the preparation of high purity Levosimendan

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9606474D0 (en) 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
BR9813213A (pt) 2000-08-29
HRP20000171A2 (en) 2000-12-31
IL134802A0 (en) 2001-04-30
CN1271282A (zh) 2000-10-25
KR100762022B1 (ko) 2007-09-28
RS49708B (sr) 2007-12-31
ATE260659T1 (de) 2004-03-15
JP4493840B2 (ja) 2010-06-30
SK3842000A3 (en) 2000-09-12
HUP0003757A2 (hu) 2001-05-28
YU17700A (sh) 2002-10-18
PT1014987E (pt) 2004-06-30
MXPA00002956A (es) 2003-05-19
GEP20032943B (en) 2003-04-25
IL134802A (en) 2004-01-04
AU9350698A (en) 1999-04-23
PL339461A1 (en) 2000-12-18
KR20010030679A (ko) 2001-04-16
EP1014987B1 (en) 2004-03-03
FI973804A0 (fi) 1997-09-26
JP2001517702A (ja) 2001-10-09
CN1149994C (zh) 2004-05-19
BG64746B1 (bg) 2006-02-28
FI973804A7 (fi) 1999-03-27
NO20001585D0 (no) 2000-03-27
ES2217580T3 (es) 2004-11-01
EE200000187A (et) 2001-04-16
TR200000635T2 (tr) 2000-09-21
EA200000360A1 (ru) 2000-10-30
NZ503207A (en) 2001-04-27
PL190862B1 (pl) 2006-02-28
WO1999016443A1 (en) 1999-04-08
NO320047B1 (no) 2005-10-17
CZ2000919A3 (cs) 2000-09-13
BG104250A (en) 2000-12-29
EE03854B1 (et) 2002-10-15
EP1014987A1 (en) 2000-07-05
HK1032001A1 (en) 2001-07-06
AU732489B2 (en) 2001-04-26
HUP0003757A3 (en) 2001-07-30
AR013519A1 (es) 2000-12-27
CA2304702C (en) 2007-09-04
EA001647B1 (ru) 2001-06-25
US6355269B1 (en) 2002-03-12
HRP20000171B1 (en) 2009-06-30
DE69822172D1 (de) 2004-04-08
ID24486A (id) 2000-07-20
CA2304702A1 (en) 1999-04-08
SK283187B6 (sk) 2003-03-04
DK1014987T3 (da) 2004-05-24
SI1014987T1 (en) 2004-08-31
CZ294984B6 (cs) 2005-04-13
MY118156A (en) 2004-09-30
DE69822172T2 (de) 2005-02-24

Similar Documents

Publication Publication Date Title
NO20001585D0 (no) Orale sammensetninger av levosimendan
ID19097A (id) Komposisi-komposisi oral
ID20233A (id) Komposisi oral
LU90115B1 (fr) Formulation orale de 2-méthyl-thiéno-benzodiazépine
DE69800983D1 (de) Verdickte filmbildende Zusammensetzung
IS2325B (is) Örgerðar samsetningar epleróns
TR199501447A2 (tr) Oral bilesimler.
ID26720A (id) Komposisi oral
DK1298194T3 (da) Staniolholdige sammensætninger
EP0836470A4 (en) ORAL COMPOSITIONS
NO993096D0 (no) Orale cyklosporinformuleringer
NO20021834L (no) Orale formuleringer av anti-tumorforbindelser
DE69838290D1 (de) Vernetzungszusammensetzungen
NO962491D0 (no) Orale formuleringer av S(+)-etodolac
BR9510467A (pt) Composições orais
DE69926907T2 (de) Bleichungzusammensetzungen
BR9510307A (pt) Composições orais
DK0966299T3 (da) Hidtil ukendte orale formuleringer af calcitonin.
DK1023035T3 (da) Mundplejemiddel
ATE263550T1 (de) Orale cyclosporinformulierungen
ID20466A (id) Komposisi oral
DE69826706D1 (de) Wäscheweichmittelzusammensetzungen
BR9606974A (pt) Composições orais
FI980902A7 (fi) Levosimendaanin stabiileja koostumuksia
ID19246A (id) Komposisi oral antikalkulus

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees